Jean P. Roy

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.

Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.

Journal: Bone marrow transplantation

Published: January 21, 2026

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Journal: Open forum infectious diseases

Published: December 23, 2025

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.

Journal: Case reports in hematology

Published: October 29, 2025

Tumor flare pain reaction following bispecific T-Cell engagers in multiple myeloma: a unique and underrecognized toxicity.

Tumor flare pain reaction following bispecific T-Cell engagers in multiple myeloma: a unique and underrecognized toxicity.

Journal: Haematologica

Published: September 07, 2025

From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation.

From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter Transformation.

Journal: Current oncology (Toronto, Ont.)

Published: August 26, 2025

A new era of complement inhibition: are we ready for the infectious risks?

A new era of complement inhibition: are we ready for the infectious risks?

Journal: Pediatric nephrology (Berlin, Germany)

Published: July 30, 2025

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Journal: Transplantation and cellular therapy

Published: June 10, 2025

Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study.

Using virtual reality hypnosis during stem cell transplant for patients in hematology: A protocol for a feasibility randomized study.

Journal: PloS one

Published: April 14, 2025

Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma.

Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma.

Journal: Current oncology (Toronto, Ont.)

Published: March 29, 2025

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center.

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center.

Journal: Current oncology (Toronto, Ont.)

Published: March 24, 2025

Prognostic value and kinetic patterns of measurable residual disease following tandem autologous/allogeneic transplant in newly diagnosed myeloma patients.

Prognostic value and kinetic patterns of measurable residual disease following tandem autologous/allogeneic transplant in newly diagnosed myeloma patients.

Journal: Bone marrow transplantation

Published: March 20, 2025

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.

Journal: Hematology (Amsterdam, Netherlands)

Published: January 07, 2025

Showing 1-12 of 45

Last Updated: 09/26/2026